Terms: = Lung cancer AND RUNX1T1, ENSG00000079102, 862 AND Treatment
57 results:
1. Efficacy of osimertinib in patients with EGFR-mutation positive non-small cell lung cancer with malignant pleural effusion.
Kiritani A; Amino Y; Uchibori K; Akita T; Harutani Y; Ogusu S; Tsugitomi R; Manabe R; Ariyasu R; Kitazono S; Yanagitani N; Nishio M
Thorac Cancer; 2024 Feb; 15(5):402-409. PubMed ID: 38226415
[TBL] [Abstract] [Full Text] [Related]
2. Impact of BMI on the survival outcomes of non-small cell lung cancer patients treated with immune checkpoint inhibitors: a meta-analysis.
Zhang T; Li S; Chang J; Qin Y; Li C
BMC Cancer; 2023 Oct; 23(1):1023. PubMed ID: 37872469
[TBL] [Abstract] [Full Text] [Related]
3. Preoperative CT findings and prognosis of pulmonary sarcomatoid carcinoma: comparison with conventional NSCLC of similar tumor size.
Tang W; Wen C; Pei Y; Wu Z; Zhong J; Peng J; Zhong J
BMC Med Imaging; 2023 Aug; 23(1):105. PubMed ID: 37580691
[TBL] [Abstract] [Full Text] [Related]
4. Development and validation of a nomogram for risk of pulmonary metastasis in non-papillary thyroid carcinoma: A SEER-based study.
Li Y; Gao X; Guo T; Liu J
Medicine (Baltimore); 2023 Aug; 102(32):e34581. PubMed ID: 37565907
[TBL] [Abstract] [Full Text] [Related]
5. Cardiovascular Disease and Mortality in Black Women Carrying the Amyloidogenic V122I Transthyretin Gene Variant.
Haring B; Hunt RP; Shadyab AH; Eaton C; Kaplan R; Martin LW; Panjrath G; Kuller LH; Assimes T; Kooperberg C; Wassertheil-Smoller S
JACC Heart Fail; 2023 Sep; 11(9):1189-1199. PubMed ID: 36930136
[TBL] [Abstract] [Full Text] [Related]
6. Temporal trends and outcomes in acute ischaemic stroke patients with a current or historical diagnosis of cancer.
Peng C; Yang F; Peng L; Zhang C; Lin Z; Chen C; Gao H; He J; Jin Z
Eur J Neurol; 2023 Apr; 30(4):951-962. PubMed ID: 36704907
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic and clinicopathological significance of CD155 expression in cancer patients: a meta-analysis.
Zhang D; Liu J; Zheng M; Meng C; Liao J
World J Surg Oncol; 2022 Oct; 20(1):351. PubMed ID: 36309698
[TBL] [Abstract] [Full Text] [Related]
8. Predictors of Secondary lung cancer Among Hodgkin Lymphoma Survivors: A Nationwide Analysis.
Alnimer Y; Ali MKM
Clin Lung Cancer; 2022 Dec; 23(8):e510-e518. PubMed ID: 36008241
[TBL] [Abstract] [Full Text] [Related]
9. Using machine learning for mortality prediction and risk stratification in atezolizumab-treated cancer patients: Integrative analysis of eight clinical trials.
Wu Y; Zhu W; Wang J; Liu L; Zhang W; Wang Y; Shi J; Xia J; Gu Y; Qian Q; Hong Y
Cancer Med; 2023 Feb; 12(3):3744-3757. PubMed ID: 35871390
[TBL] [Abstract] [Full Text] [Related]
10. Incidental findings on routine preoperative noncontrast chest computed tomography and chest radiography prior to cardiac surgery in the multicenter randomized controlled CRICKET study.
Knol WG; den Harder AM; de Heer LM; Benke K; Maurovich-Horvat P; Leiner T; Merkely B; Krestin GP; Bogers AJJC; Budde RPJ
Eur Radiol; 2023 Jan; 33(1):294-301. PubMed ID: 35852576
[TBL] [Abstract] [Full Text] [Related]
11. Randomized Phase 2 Study of Osimertinib Plus Bevacizumab Versus Osimertinib for Untreated Patients With Nonsquamous NSCLC Harboring EGFR Mutations: WJOG9717L Study.
Kenmotsu H; Wakuda K; Mori K; Kato T; Sugawara S; Kirita K; Yoneshima Y; Azuma K; Nishino K; Teraoka S; Shukuya T; Masuda K; Hayashi H; Toyozawa R; Miura S; Fujimoto D; Nakagawa K; Yamamoto N; Takahashi T
J Thorac Oncol; 2022 Sep; 17(9):1098-1108. PubMed ID: 35636696
[TBL] [Abstract] [Full Text] [Related]
12. Biomarkers of systemic inflammation predict survival with first-line immune checkpoint inhibitors in non-small-cell lung cancer.
Stares M; Ding TE; Stratton C; Thomson F; Baxter M; Cagney H; Cumming K; Swan A; Ross F; Barrie C; Maclennan K; Campbell S; Evans T; Tufail A; Harrow S; Lord H; Laird B; MacKean M; Phillips I
ESMO Open; 2022 Apr; 7(2):100445. PubMed ID: 35398717
[TBL] [Abstract] [Full Text] [Related]
13. Results of emergency salvage lung resection after chemo- and/or radiotherapy among patients with lung cancer.
Hino H; Utsumi T; Maru N; Matsui H; Taniguchi Y; Saito T; Tsuta K; Murakawa T
Interact Cardiovasc Thorac Surg; 2022 Jun; 35(1):. PubMed ID: 35253874
[TBL] [Abstract] [Full Text] [Related]
14. Prognosis by cancer type and incidence of zoledronic acid-related osteonecrosis of the jaw: a single-center retrospective study.
Hata H; Imamachi K; Ueda M; Matsuzaka M; Hiraga H; Osanai T; Harabayashi T; Fujimoto K; Oizumi S; Takahashi M; Yoshikawa K; Sato J; Yamazaki Y; Kitagawa Y
Support Care Cancer; 2022 May; 30(5):4505-4514. PubMed ID: 35113225
[TBL] [Abstract] [Full Text] [Related]
15. Prediction of invasive adenocarcinomas manifesting as pure ground-glass nodules based on radiomic signature of low-dose CT in lung cancer screening.
Li Y; Liu J; Yang X; Xu H; Qing H; Ren J; Zhou P
Br J Radiol; 2022 May; 95(1133):20211048. PubMed ID: 34995082
[TBL] [Abstract] [Full Text] [Related]
16. Pharmacovigilance Analysis of Cardiac Toxicities Associated With Targeted Therapies for Metastatic NSCLC.
Waliany S; Zhu H; Wakelee H; Padda SK; Das M; Ramchandran K; Myall NJ; Chen T; Witteles RM; Neal JW
J Thorac Oncol; 2021 Dec; 16(12):2029-2039. PubMed ID: 34418561
[TBL] [Abstract] [Full Text] [Related]
17. Percutaneous lung microwave ablation versus lung resection in high-risk patients. A monocentric experience.
Mendogni P; Daffrè E; Rosso L; Palleschi A; Righi I; Carrinola R; Damarco F; Polli F; Ierardi A; Arrichiello A; Carrafiello G; Nosotti M; Tosi D
Acta Biomed; 2020 Sep; 91(10-S):e2020002. PubMed ID: 33245066
[TBL] [Abstract] [Full Text] [Related]
18. Association of baseline systemic corticosteroid use with overall survival and time to next treatment in patients receiving immune checkpoint inhibitor therapy in real-world US oncology practice for advanced non-small cell lung cancer, melanoma, or urothelial carcinoma.
Drakaki A; Dhillon PK; Wakelee H; Chui SY; Shim J; Kent M; Degaonkar V; Hoang T; McNally V; Luhn P; Gutzmer R
Oncoimmunology; 2020 Oct; 9(1):1824645. PubMed ID: 33101774
[TBL] [Abstract] [Full Text] [Related]
19. Multicenter Cohort Study to Assess the Association between Changes on Imaging and Outcome after Regorafenib treatment (KSCC1603).
Oki E; Kawahira M; Kusumoto T; Yuki S; Hatanaka K; Kobayashi Y; Nishie A; Kawanami S; Makiyama A; Saeki H; Sakamoto S; Komatsu Y; Shimokawa M; Mori M; Esaki T
Oncology; 2020; 98(10):719-726. PubMed ID: 32640458
[TBL] [Abstract] [Full Text] [Related]
20. Is There a Role for Hypofractionated Thoracic Radiation Therapy in Limited-Stage Small Cell lung cancer? A Propensity Score Matched Analysis.
Zayed S; Chen H; Ali E; Rodrigues GB; Warner A; Palma DA; Louie AV
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):575-586. PubMed ID: 32544575
[TBL] [Abstract] [Full Text] [Related]
[Next]
